CIK 0001108205 · Non-accelerated filer<br>Smaller reporting company
CURIS INC
Sign in to watch- Ticker
- CRIS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043505116
- Phone
- 617-503-6500
- Business address
- 128 SPRING STREET, BUILDING C, SUITE 500, LEXINGTON, MA, 02421
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2009-02-05 | TOBIN JAMES R Director | Grant or award · Non-qualified stock option (right to buy) | +17,500 | 17,500 | ||
| 2009-02-05 | MCNAB JAMES R Director | Grant or award · Non-qualified stock option | +7,500 | 7,500 | ||
| 2009-02-05 | MCNAB JAMES R Director | Grant or award · Non-qualified stock option (right to buy) | +87,500 | 87,500 | ||
| 2009-02-05 | PASSERI DANIEL R CEO and Director | Grant or award · Qualified stock option (right to buy) | +18,750 | 18,750 | ||
| 2009-02-05 | PASSERI DANIEL R CEO and Director | Grant or award · Non-qualified stock option (right to buy) | +281,250 | 281,250 | ||
| 2009-02-05 | GRAY MICHAEL COO and CFO | Grant or award · Qualified stock option (right to buy) | +20,210 | 20,210 | ||
| 2009-02-05 | GRAY MICHAEL COO and CFO | Grant or award · Non-qualified stock option (right to buy) | +159,790 | 159,790 | ||
| 2009-02-05 | Qian Changgeng VP, Research & Preclinical Dev | Grant or award · Qualified stock option (right to buy) | +20,210 | 20,210 | ||
| 2009-02-05 | Qian Changgeng VP, Research & Preclinical Dev | Grant or award · Non-qualified stock option (right to buy) | +159,790 | 159,790 | ||
| 2009-02-05 | Qian Changgeng VP, Research & Preclinical Dev | Grant or award · Qualified stock option (right to buy) | +20,210 | 20,210 | ||
| 2009-02-05 | Qian Changgeng VP, Research & Preclinical Dev | Grant or award · Non-qualified stock option (right to buy) | +159,790 | 159,790 | ||
| 2008-12-30 | MCNAB JAMES R Director | Gift | −25,000 | 799,688 | ||
| 2008-10-24 | NOEL MARK Vice-President | Grant or award · Non-qualified stock option (right to buy) | +43,000 | $0.79 | $34K | 43,000 |
| 2008-10-24 | Qian Changgeng VP, Research & Preclinical Dev | Grant or award · Non-qualified stock option (right to buy) | +51,000 | $0.79 | $40K | 51,000 |
| 2008-10-24 | GRAY MICHAEL COO and CFO | Grant or award | +79,113 | $0.01 | $791 | 86,613 |
| 2008-10-24 | PASSERI DANIEL R CEO and Director | Grant or award · Non-qualified stock option (right to buy) | +202,000 | $0.79 | $160K | 202,000 |
| 2008-10-01 | PASSERI DANIEL R CEO | Option exercise | +20,000 | $1.09 | $22K | 75,000 |
| 2008-10-01 | PASSERI DANIEL R CEO | Option exercise · Non-qualified stock option (right to buy) | +20,000 | $1.09 | $22K | 52,813 |
| 2008-10-01 | GRAY MICHAEL COO and CFO | Option exercise | +7,500 | $1.09 | $8K | 7,500 |
| 2008-10-01 | GRAY MICHAEL COO and CFO | Option exercise · Qualified stock option | +7,500 | $1.09 | $8K | 26,250 |
Page 26 of 29 · 564 trades